AXA S.A. - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 189 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.

Quarter-by-quarter ownership
AXA S.A. ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2021$287,000
-91.3%
6,400
-88.9%
0.00%
-90.0%
Q4 2020$3,303,000
+15.4%
57,879
+3.7%
0.01%0.0%
Q3 2020$2,863,000
-62.0%
55,807
-55.8%
0.01%
-33.3%
Q2 2020$7,536,000
+34.1%
126,204
-7.6%
0.02%
+7.1%
Q1 2020$5,620,000
+6.0%
136,542
-41.9%
0.01%
+40.0%
Q2 2019$5,304,000
+81.6%
235,172
+86.8%
0.01%
-9.1%
Q1 2019$2,921,000
+10.6%
125,8640.0%0.01%
-8.3%
Q4 2018$2,642,000
-45.8%
125,8640.0%0.01%
-33.3%
Q3 2018$4,873,000
+50.7%
125,864
+53.1%
0.02%
+50.0%
Q2 2018$3,234,00082,1960.01%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q4 2020
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$15,385,74319.76%
Redmile Group, LLC 4,475,384$56,926,8842.71%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,897,606$87,737,5481.93%
Parkman Healthcare Partners LLC 597,403$7,598,9661.39%
Ghost Tree Capital, LLC 325,000$4,134,0001.36%
BRAIDWELL LP 3,336,221$42,436,7311.34%
AlphaCentric Advisors LLC 132,000$1,679,0400.95%
ARMISTICE CAPITAL, LLC 4,612,000$58,664,6400.90%
Sunesis Advisors, LLC 96,299$1,224,9230.87%
EcoR1 Capital, LLC 993,000$12,630,9600.43%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders